Cargando…
Geometric dose prediction model for hemithoracic intensity‐modulated radiation therapy in mesothelioma patients with two intact lungs
The presence of two intact lungs makes it challenging to reach a tumoricidal dose with hemithoracic pleural intensity‐modulated radiation therapy (IMRT) in patients with malignant pleural mesothelioma (MPM) who underwent pleurectomy/decortications or have unresectable disease. We developed an anatom...
Autores principales: | Kuo, LiCheng, Yorke, Ellen D., Dumane, Vishruta A., Foster, Amanda, Zhang, Zhigang, Mechalakos, James G., Wu, Abraham J., Rosenzweig, Kenneth E., Rimner, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513486/ https://www.ncbi.nlm.nih.gov/pubmed/27167294 http://dx.doi.org/10.1120/jacmp.v17i3.6199 |
Ejemplares similares
-
Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary Study
por: Crovella, Sergio, et al.
Publicado: (2021) -
Olaparib increases the therapeutic index of hemithoracic irradiation compared with hemithoracic irradiation alone in a mouse lung cancer model
por: Jiang, Yanyan, et al.
Publicado: (2021) -
Radical Hemithoracic Radiotherapy Induces Systemic Metabolomics Changes That Are Associated with the Clinical Outcome of Malignant Pleural Mesothelioma Patients
por: Di Gregorio, Emanuela, et al.
Publicado: (2021) -
Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT
por: Dumane, Vishruta A., et al.
Publicado: (2018) -
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)
por: Hasegawa, Seiki, et al.
Publicado: (2015)